Correlation Between Centum Electronics and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centum Electronics and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centum Electronics and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centum Electronics Limited and Beta Drugs, you can compare the effects of market volatilities on Centum Electronics and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centum Electronics with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centum Electronics and Beta Drugs.

Diversification Opportunities for Centum Electronics and Beta Drugs

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Centum and Beta is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Centum Electronics Limited and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Centum Electronics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centum Electronics Limited are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Centum Electronics i.e., Centum Electronics and Beta Drugs go up and down completely randomly.

Pair Corralation between Centum Electronics and Beta Drugs

Assuming the 90 days trading horizon Centum Electronics Limited is expected to generate 2.91 times more return on investment than Beta Drugs. However, Centum Electronics is 2.91 times more volatile than Beta Drugs. It trades about 0.23 of its potential returns per unit of risk. Beta Drugs is currently generating about -0.02 per unit of risk. If you would invest  162,060  in Centum Electronics Limited on September 23, 2024 and sell it today you would earn a total of  51,075  from holding Centum Electronics Limited or generate 31.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Centum Electronics Limited  vs.  Beta Drugs

 Performance 
       Timeline  
Centum Electronics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Centum Electronics Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Centum Electronics sustained solid returns over the last few months and may actually be approaching a breakup point.
Beta Drugs 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Centum Electronics and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centum Electronics and Beta Drugs

The main advantage of trading using opposite Centum Electronics and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centum Electronics position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Centum Electronics Limited and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing